College of Medicine (UK)

Albert Einstein College of Medicine and Montefiore Health System Receive $5.2 Million NIH Grant to Study Heart Failure in Hispanic Populations

Retrieved on: 
Thursday, December 15, 2022
Heart, Health, 2009 Davis Cup, Cancer, Heart failure, Cardiology, AIDS, Hudson Valley, Albert Einstein College of Medicine, Pediatrics, Woman, Epidemiology, Hypertension, Teaching hospital, Student, Risk, NIH, Partnership, National Heart, Lung, and Blood Institute, College, Death, Obesity, Trial of the century, Ageing, Hospital, Liver disease, Transplant, Aorta, Framingham Heart Study, Lung, College of Medicine (UK), Diabetes, Black, Montefiore Medical Center, Doctor of Philosophy, Albert Einstein, Patient, University Hospital (Newark, New Jersey), Research, Incidence, Medicine, Degenerative disease, Neuroscience, Pharmaceutical industry, Medical device, Montefiore

, principal investigator on the grant, professor of medicine and of epidemiology & population health at Einstein and director of clinical cardiology research and of cardiovascular epidemiology at Einstein and Montefiore.

Key Points: 
  • , principal investigator on the grant, professor of medicine and of epidemiology & population health at Einstein and director of clinical cardiology research and of cardiovascular epidemiology at Einstein and Montefiore.
  • "This funding will help us better understand and predict heart failure among Hispanicsand potentially other population groups."
  • Compared with non-Hispanic whites, Hispanics/Latinos have a higher incidence of heart failure, tend to develop heart failure earlier, and tend to have more comorbidities accompanying heart disease, such as diabetes, obesity and hypertension.
  • Albert Einstein College of Medicine is one of the nation's premier centers for research, medical education and clinical investigation.

Albert Einstein College of Medicine Researchers Develop Promising New Cancer Therapy

Retrieved on: 
Tuesday, November 15, 2022
Albert Einstein College of Medicine, Technology, NK, Immunotherapy, Immunity, Student, YouTube, Microbiology, College, Melanoma, Ageing, Squamous cell carcinoma, University Hospital (Newark, New Jersey), AIDS, Diabetes, National, Lung, Attention, Lymphoma, PVR, Stomach, Partnership, Myeloid leukemia, Liver disease, Patient, Degenerative disease, Protein, Pembrolizumab, Paper, Pancreatic cancer, College of Medicine, Doctor of Philosophy, Montefiore, Microdeletion syndrome, Journal, Urology, Teaching hospital, Journal of Clinical Investigation, Multimedia, College of Medicine (UK), Head, Neuroscience, Neoplasm, JCI, Neck, TIGIT, Acute myeloid leukemia, Research, Patent, Albert Einstein, Large-cell lung carcinoma, Cancer research, Pharmaceutical industry, Vaccine, Cancer, Medicine, Facebook

Their introduction a decade ago marked a major advance in cancer therapy, but only 10% to 30% of treated patients experience long-term improvement.

Key Points: 
  • Their introduction a decade ago marked a major advance in cancer therapy, but only 10% to 30% of treated patients experience long-term improvement.
  • In a paper published online today in The Journal of Clinical Investigation (JCI), scientists at Albert Einstein College of Medicine describe findings that could bolster the effectiveness of immune-checkpoint therapy.
  • Rather than rally T cells against cancer, the Einstein research team used different human immune cells known as natural killer (NK) cellswith dramatic results.
  • About Albert Einstein College of Medicine Albert Einstein College of Medicine is one of the nation's premier centers for research, medical education and clinical investigation.

Researchers Receive $4.2M Grant to Improve PrEP Access and Prevent New HIV Infections

Retrieved on: 
Wednesday, September 21, 2022
People, Neuroscience, YouTube, National, EDS, City University, Time, Infection, Medicine, Doctor of Philosophy, Ageing, Twitter, Risk, STI, College of Medicine (UK), Hunter College, Blog, Albert Einstein College of Medicine, Hospital, College, Transplant, Degenerative disease, Teaching hospital, HIV, HIV/AIDS research, LinkedIn, Liver disease, Hudson Valley, Psychology, Health, Montefiore Medical Center, Partnership, Albert Einstein, University Hospital (Newark, New Jersey), Patient, Cancer, Diabetes, Office of Inspector General, U.S. Department of Health and Human Services, Pediatrics, Instagram, Student, Cardiology, Diagnosis, ED, Research, AIDS, Multimedia, Poverty, ERC, HIV/AIDS, Education, Pharmaceutical industry, Facebook, Montefiore

BRONX, N.Y., Sept. 21, 2022 /PRNewswire/ -- Bronx county has the country's fifth-highest rate of HIV diagnosis—but the lowest rate in New York State for use of HIV pre-exposure prophylaxis (PrEP), medications that are extremely effective in preventing HIV infection. Physician-researchers at Albert Einstein College of Medicine and Montefiore Health System have received a five-year, $4.2 million grant from the National Institutes of Health to compare two strategies for improving PrEP access and use in the Bronx.  

Key Points: 
  • "Our goal," Dr. Felsen said "is to meet Bronx residents where they are in order to improve PrEP access and reduce HIV infection rates."
  • Many people at risk for HIV seek care for sexually transmitted infections (STIs) in emergency departments (EDs).
  • The navigator will provide PrEP education and attempt to enroll these patients in ongoing sexual and HIV preventive care.
  • The grant is titled "ED2PrEP - patient focused, low-burden strategies for PrEP uptake among emergency departments patients: a cross-over hybrid implementation-effectiveness trial."

Research Reveals Secrets of Baffling but All-Too-Common Type of Diabetes

Retrieved on: 
Thursday, June 2, 2022
HIV/AIDS, Neuroscience, Albert Einstein College of Medicine, Liver disease, Research, Cell, Harold, Harvard Medical School, Food, Ageing, Partnership, News, Disease, College of Medicine (UK), Awareness, YouTube, Blood, Underweight, Multimedia, Insulin resistance, University Hospital (Newark, New Jersey), Male, National, Patient, Student, Doctor of Philosophy, New York University, Insulin, Cancer, T2D, College, Food and Drug Administration, Diagnosis, AIDS, Twitter, Obesity, Glucose, Prevalence, Christian Medical College Vellore, Degenerative disease, Blog, Teaching hospital, Albert Einstein, Death, Montefiore, Pharmaceutical industry, Medical device, T1D, Facebook, Diabetes Care, Diabetes, Medicine, MD

Their young age and thinness suggest type 1 diabetes (T1D), but insulin injections usually don't help and can even cause death from low blood sugar.

Key Points: 
  • Their young age and thinness suggest type 1 diabetes (T1D), but insulin injections usually don't help and can even cause death from low blood sugar.
  • Nor do patients seem to have type 2 diabetes (T2D), which is typically associated with obesity.
  • The research was conducted at the renowned Christian Medical College in Vellore, India, in collaboration with Dr. Hawkins and other members of the Global Diabetes Institute.
  • This includes the funding of major research centers at Einstein in cancer, aging, intellectual development disorders, diabetes, clinical and translational research, liver disease, and AIDS.

Montefiore Einstein Cancer Center Researchers Receive Price Family Foundation Health Equity Research Awards

Retrieved on: 
Thursday, May 19, 2022
Cancer, Diabetes, Doctor of Philosophy, Medicine, Hospital, Transplant, Cardiology, Science, Patient, Prostate, Multimedia, Teaching hospital, MECC, Health, AIDS, University Hospital (Newark, New Jersey), College, Degenerative disease, Color, Albert Einstein, BIPOC, Research, Pediatrics, Hudson Valley, Partnership, Liver disease, Carol, Student, YouTube, Instagram, Neck, Albert Einstein College of Medicine, Blog, College of Medicine (UK), HIV disease progression rates, National Cancer Institute, Ageing, Montefiore Medical Center, Lung, Head, LinkedIn, Twitter, National, Neuroscience, Health equity, Black–brown unity, Pharmaceutical industry, Montefiore, Facebook, Cancer Medicine

BRONX, N.Y., May 19, 2022 /PRNewswire/ -- The National Cancer Institute-designated Montefiore Einstein Cancer Center (MECC) has partnered with the Price Family Foundation to fund eight research teams developing novel cancer therapies and improving cancer outcomes for historically marginalized communities in the Bronx.

Key Points: 
  • BRONX, N.Y., May 19, 2022 /PRNewswire/ -- The National Cancer Institute-designated Montefiore Einstein Cancer Center (MECC) has partnered with the Price Family Foundation to fund eight research teams developing novel cancer therapies and improving cancer outcomes for historically marginalized communities in the Bronx.
  • The inaugural Price Family Foundation Health Equity Pilot Awards will provide $200,000 in funding over two years to each team and support basic science, translational, and clinical investigators focusing on cancers that are highly prevalent in the Bronx.
  • , director of the MECC; vice president for cancer medicine at Montefiore Health System ; and the Carol and Roger Einiger Professor of Cancer Medicine and professor of medicine, of oncology, and of molecular pharmacology at Albert Einstein College of Medicine .
  • "We are grateful to have found a partner in the Price Family Foundation, which believes, as we do, in the importance of research that promotes health equity in the Bronx, which will inform cancer care here at our cancer center and throughout the country."

OSF HealthCare collaborates to test blockchain-based app to reward healthy behaviors

Retrieved on: 
Tuesday, May 10, 2022
Champaign County, Illinois, Innovation, Nursing, Privacy, Museum, Data, Grainger College of Engineering, Business, Outcomes research, University, Student, Health, Third order, Bed, UIUC, Research, Blockchain, Physician, College, ARCHES, German Cancer Research Center, Faculty, Gies College of Business, Sister, Diagnosis, Hospital, University of Cincinnati College of Engineering and Applied Science, Virtual reality, Behavior, University of Illinois Urbana-Champaign, Immersion, Center, OSF, University of Illinois College of Medicine, Education, Applied science, Solution, College of Medicine (UK), Partner (business rank), Technology, Community health, OSF HealthCare, Multimedia, Illinois College, Management, Cryptocurrency, Video game console, Online shopping, Pharmaceutical industry, Medicine, Jump, Engineering

Ralph says consumers using the blockchain-based rewards app could be rewarded quickly for exercising, taking medication, or any number of other healthy behaviors, unlike the kinds of programs insurance companies currently offer clients.

Key Points: 
  • Ralph says consumers using the blockchain-based rewards app could be rewarded quickly for exercising, taking medication, or any number of other healthy behaviors, unlike the kinds of programs insurance companies currently offer clients.
  • Other systems (insurance reward programs), will take a lot longer and it'll be harder to see directly the impact of what you're doing."
  • OSF HealthCare, through OSF Home Care Services, operates an extensive network of home health and hospice services.
  • Jump Trading Simulation and Education Center, a part of OSF Innovation , is a collaboration between University of Illinois College of Medicine at Peoria and OSF HealthCare.

Albert Einstein College of Medicine Receives $4.2 Million NIH Grant to Discover Novel Markers of Early Alzheimer's Disease

Retrieved on: 
Tuesday, April 26, 2022
Ageing, Liver disease, Magnetic resonance imaging, Degenerative disease, NIH, College, Neurology, Pathology, University Hospital (Newark, New Jersey), Twitter, Research, Saul, MRI, Doctor of Philosophy, YouTube, National, Neuroscience, Patient, Blog, Walking, Mark (given name), Student, Albert Einstein College of Medicine, AIDS, National Institute on Aging, Albert Einstein, Teaching hospital, Falls, National Institute, National Institutes of Health, Montefiore, Diabetes, Multimedia, Disease, Quality of life, Gait, Risk, Partnership, Memory, Cancer, College of Medicine (UK), Medical imaging, Pharmaceutical industry, Alzheimer's disease, Facebook

Now, researchers at Albert Einstein College of Medicine have been awarded a five-year, $4.2 million National Institutes of Health (NIH) grant to detect behavioral markers for Alzheimer's that are present early in the course of the disease, before it can be clinically diagnosed.

Key Points: 
  • Now, researchers at Albert Einstein College of Medicine have been awarded a five-year, $4.2 million National Institutes of Health (NIH) grant to detect behavioral markers for Alzheimer's that are present early in the course of the disease, before it can be clinically diagnosed.
  • Using non-invasive techniques, we hope to discover whether novel behavioral indicators can identify people who have pre-clinical Alzheimer's disease.
  • The grant, "Visual-somatosensory integration as a novel marker of Alzheimer's disease," is funded by the National Institute on Aging, part of the NIH (1R01AG075679).
  • Albert Einstein College of Medicine is one of the nation's premier centers for research, medical education and clinical investigation.

Einstein Aging Study Receives $32 Million Grant to Study Alzheimer's Disease

Retrieved on: 
Wednesday, April 20, 2022
Ageing, Air pollution, Medicine, Epidemiology, Liver disease, Sleep, Montefiore Medical Center, Thought, Degenerative disease, NIH, College, Faculty, Dementia, University Hospital (Newark, New Jersey), Twitter, Risk, Research, Saul, Diagnosis, Alzheimer's disease, Brain, Doctor of Philosophy, YouTube, EAS, Death, National, Neuroscience, Patient, Kathleen Lindsay, Blog, Pennsylvania State University, Smartphone, College of Arts and Sciences, Student, Albert Einstein College of Medicine, AIDS, Edwin, Albert Einstein, Method, Teaching hospital, Cognition, National Institute, Montefiore, Diabetes, Multimedia, Disease, Partnership, Black, Psychiatry, Health, Cancer, College of Medicine (UK), National Institute on Aging, Pharmaceutical industry, Medical device, Toy, Neurology, Facebook

"In our fifth decade of the Einstein Aging Study, we are well-positioned to build on our earlier findings to identify ways to delay the onset and progression of Alzheimer's disease," said Richard Lipton, M.D.

Key Points: 
  • "In our fifth decade of the Einstein Aging Study, we are well-positioned to build on our earlier findings to identify ways to delay the onset and progression of Alzheimer's disease," said Richard Lipton, M.D.
  • Some 6.5 million people over 65 have the disease todaya number predicted to edge closer to 13 million by 2050.
  • The grant, "Einstein Aging Study," is funded by the National Institute on Aging, part of the NIH (2P01AG003949-38).
  • This includes the funding of major research centers at Einstein in cancer, aging, intellectual development disorders, diabetes, clinical and translational research, liver disease, and AIDS.

For The Second Year in a Row, Two Einstein Research Teams Win Competitive XSeed Awards

Retrieved on: 
Tuesday, March 8, 2022
Faculty, Multiple sclerosis, Lists of video games, Industry, KIF1A, Blog, National, Montefiore, Twitter, ALS, University Hospital (Newark, New Jersey), Partnership, Research, Ageing, AIDS, Teaching hospital, Albert Einstein, Neuroscience, Cancer, Neurodegeneration, Autism, Albert Einstein College of Medicine, Diabetes, Health, Lists of diseases, Multimedia, Neuron, College, KAND, Mentorship, Science, Marilyn, Patient, College of Medicine (UK), YouTube, Doctor of Philosophy, Allograft inflammatory factor 1, Degenerative disease, Biotechnology, Diagnosis, Intellectual disability, Student, Liver disease, Pharmaceutical industry, Facebook

, the Marilyn and Stanley M. Katz Dean at Einstein and executive vice president and chief academic officer at Montefiore Medicine.

Key Points: 
  • , the Marilyn and Stanley M. Katz Dean at Einstein and executive vice president and chief academic officer at Montefiore Medicine.
  • Winners of the 2022 XSeed Awards are:
    Arne Gennerich, Ph.D. , and Hernando Sosa, Ph.D. , for their proposal to identify and develop drugs targeting neurodevelopmental and neurodegenerative diseases.
  • Albert Einstein College of Medicine is one of the nation's premier centers for research, medical education and clinical investigation.
  • This includes the funding of major research centers at Einstein in cancer, aging, intellectual development disorders, diabetes, clinical and translational research, liver disease, and AIDS.

Latest Jump ARCHES awards focus on medical tech solutions to address vexing health care challenges

Retrieved on: 
Thursday, January 20, 2022
Medicine, Champaign County, Illinois, Research, OSF HealthCare, Data, Partner (business rank), Museum, University of Illinois Urbana-Champaign, College of Medicine (UK), Physician, Athlete, Concussion, Outcomes research, University of Illinois College of Medicine, Technology, COVID-19, Social, Third order, Digital health, Student, Kansas State University College of Engineering, Psychiatry Innovation Lab, Multimedia, Applied science, Hospital, Intubation, Grainger College of Engineering, Partnership, Health literacy, News, Sister, Solution, Health, Center, Child, Education, Illinois College, Behavioural sciences, College, German Cancer Research Center, Nursing, FAAP, CSBS, Migraine, Engineering, IOT, Poverty, Bed, OSF, View, Community health, Faculty, University, Virtual reality, ARCHES, Pharmaceutical industry, Jump, MD

The funding supports research involving clinicians, engineers, and social scientists to rapidly develop technologies and devices that could revolutionize medical training and health care delivery.

Key Points: 
  • The funding supports research involving clinicians, engineers, and social scientists to rapidly develop technologies and devices that could revolutionize medical training and health care delivery.
  • He adds, "We know digitally connected health systems, powerful data analytics, and new innovative approaches offer the promise of universal standard care and health knowledge for everyone we serve."
  • HCESC designs collaborative solutions to improve health care outcomes utilizing their expertise in simulation technologies, smart health systems, data analytics, human factors and medical robotics.
  • HCESC partners with Jump in this innovative relationship of Applied Research for Community Health through Engineering and Simulation (ARCHES).